Skip to main content
. Author manuscript; available in PMC: 2018 May 15.
Published in final edited form as: Cancer Res. 2017 Apr 17;77(10):2620–2632. doi: 10.1158/0008-5472.CAN-16-3472

Figure 1.

Figure 1

Inflammation fosters CRC development in genetically engineered mice.

A) Macroscopic colon tumor counts from 12–51 week old SPF ApcMin/+;Il10−/− and ApcMin/+ mice. B) Colon combined histological inflammation scores (the average of the proximal and distal inflammation scores) from SPF ApcMin/+;Il10−/− and ApcMin/+ mice. C-D) Cecum and small intestine macroscopic tumor counts from SPF ApcMin/+;Il10−/− and ApcMin/+ mice. E) Colon H&Es from 30–40 week old SPF ApcMin/+;Il10−/− and ApcMin/+ mice (5×, 40× magnification). F) Relationship between colon inflammation score and macroscopic colon or small intestine tumors in SPF ApcMin/+;Il10−/− and ApcMin/+ mice. G) Relationship between mouse endpoint age and macroscopic tumors in SPF ApcMin/+;Il10−/− and ApcMin/+ mice. Spearman correlation r values and corresponding p values are noted in each panel. Data are expressed as mean +/− standard deviation (SD). Two-tailed Mann-Whitney statistical analysis: ****p< 0.0001, ***p< 0.001, **p< 0.01, *p< 0.05, NS: not significant.